Results
|
|
21.
|
|
|
|
22.
|
|
|
|
23.
|
|
|
|
24.
|
|
|
|
25.
|
|
|
|
26.
|
|
|
|
27.
|
|
|
|
28.
|
|
|
|
29.
|
|
|
|
30.
|
|
|
|
31.
|
[Efficacy, tolerability and safety of the treatment with teberif: the results of a 2-year randomized clinical trial of treatment naïve patients with remitting multiple sclerosis, who have not received DMT, after switching from other interferon β-1a]. [electronic resource] by
- Boyko, A N
- Bosenko, L P
- Vasilovskiy, V V
- Volkova, L I
- Zakharova, M N
- Kotov, S V
- Lekomtseva, E V
- Negrich, T I
- Parshina, E V
- Patrusheva, O P
- Prokopenko, S V
- Sazonov, D V
- Timchenko, L V
- Trinitatskiy, Yu V
- Khabirov, F A
- Khavunka, M Ya
- Chichanovskaya, L V
- Sherman, M A
- Ivanov, R A
- Lin'kova, Yu N
- Stukalina, E Yu
- Zinkina-Orikhan, A V
- Obukhova, I G
Producer: 20190826
In:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova vol. 119
Availability: No items available.
|
|
|
32.
|
|
|
|
33.
|
|
|
|
34.
|
|
|
|
35.
|
|
|
|
36.
|
|
|
|
37.
|
|
|
|
38.
|
|
|
|
39.
|
|
|
|
40.
|
|